TY - JOUR
T1 - An official American Thoracic Society workshop report
T2 - Stem cells and cell therapies in lung biology and diseases
AU - Weiss, Daniel J.
AU - Chambers, Daniel
AU - Giangreco, Adam
AU - Keating, Armand
AU - Kotton, Darrell
AU - Lelkes, Peter I.
AU - Wagner, Darcy E.
AU - Prockop, Darwin J.
N1 - Copyright©2015 by the American Thoracic Society
PY - 2015/4/1
Y1 - 2015/4/1
N2 - The University of Vermont College of Medicine and the Vermont Lung Center, in collaboration with the NHLBI, Alpha-1 Foundation, American Thoracic Society, European Respiratory Society, International Society for Cell Therapy, and the Pulmonary Fibrosis Foundation, convened a workshop, "Stem Cells and Cell Therapies in Lung Biology and Lung Diseases, " held July 29 to August 1, 2013 at the University of Vermont. The conference objectives were to review the current understanding of the role of stem and progenitor cells in lung repair after injury and to review the current status of cell therapy and ex vivo bioengineering approaches for lung diseases. These are all rapidly expanding areas of study that both provide further insight into and challenge traditional views of mechanisms of lung repair after injury and pathogenesis of several lung diseases. The goals of the conference were to summarize the current state of the field, discuss and debate current controversies, and identify future research directions and opportunities for both basic and translational research in cell-based therapies for lung diseases. This conference was a follow-up to four previous biennial conferences held at the University of Vermont in 2005, 2007, 2009, and 2011. Each of those conferences, also sponsored by the National Institutes of Health, American Thoracic Society, and Respiratory Disease Foundations, has been important in helping guide research and funding priorities. The major conference recommendations are summarized at the end of the report and highlight both the significant progress and major challenges in these rapidly progressing fields.
AB - The University of Vermont College of Medicine and the Vermont Lung Center, in collaboration with the NHLBI, Alpha-1 Foundation, American Thoracic Society, European Respiratory Society, International Society for Cell Therapy, and the Pulmonary Fibrosis Foundation, convened a workshop, "Stem Cells and Cell Therapies in Lung Biology and Lung Diseases, " held July 29 to August 1, 2013 at the University of Vermont. The conference objectives were to review the current understanding of the role of stem and progenitor cells in lung repair after injury and to review the current status of cell therapy and ex vivo bioengineering approaches for lung diseases. These are all rapidly expanding areas of study that both provide further insight into and challenge traditional views of mechanisms of lung repair after injury and pathogenesis of several lung diseases. The goals of the conference were to summarize the current state of the field, discuss and debate current controversies, and identify future research directions and opportunities for both basic and translational research in cell-based therapies for lung diseases. This conference was a follow-up to four previous biennial conferences held at the University of Vermont in 2005, 2007, 2009, and 2011. Each of those conferences, also sponsored by the National Institutes of Health, American Thoracic Society, and Respiratory Disease Foundations, has been important in helping guide research and funding priorities. The major conference recommendations are summarized at the end of the report and highlight both the significant progress and major challenges in these rapidly progressing fields.
UR - http://www.scopus.com/inward/record.url?scp=84928724209&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84928724209&partnerID=8YFLogxK
U2 - 10.1513/AnnalsATS.201502-086ST
DO - 10.1513/AnnalsATS.201502-086ST
M3 - Review article
C2 - 25897748
AN - SCOPUS:84928724209
SN - 2329-6933
VL - 12
SP - S79-S97
JO - Annals of the American Thoracic Society
JF - Annals of the American Thoracic Society
IS - 4
ER -